does tirzepatide have fewer side effects than semaglutide vs Tirzepatide vs Semaglutide: Key Differences

But still

Projected retatrutide timeline (based on these patterns) Phase 3 trials began: 2024 (TRIUMPH program) Expected FDA submission: 2026-2027 Expected FDA approval: 2027-2028 Expected commercial availability: 2028 Expected stable widespread availability: 2029-2030 (assuming manufacturing ramp-up and shortage resolution) Key lesson from prior launches Demand for GLP-1 medications has consistently exceeded manufacturer projections

Prescriptions are only provided if clinically appropriate after a medical evaluation

Tier 3: Non-preferred brand-name drugs live here

Do-it-yourself versions of treatments like dermaplaning, light therapy, and skin flooding often promise big results, but they rarely deliver the same benefits as professional care

If this occurs, withdraw the needle immediately and select a different site with more visible fatty tissue